The Latest Headlines at American Banking and Market News
New York State Common Retirement Fund Has $866,000 Stock Position in WaFd, Inc (NASDAQ:WAFD)
New York State Common Retirement Fund decreased its stake in WaFd, Inc (NASDAQ:WAFD – Free Report) by 2.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange... More of this article »
New York State Common Retirement Fund Acquires 13,769 Shares of MarineMax, Inc. (NYSE:HZO)
New York State Common Retirement Fund grew its holdings in shares of MarineMax, Inc. (NYSE:HZO – Free Report) by 175.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission... More of this article »
New York State Common Retirement Fund Raises Stock Holdings in Cars.com Inc. (NYSE:CARS)
New York State Common Retirement Fund boosted its holdings in shares of Cars.com Inc. (NYSE:CARS – Free Report) by 60.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities &... More of this article »
Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by New York State Common Retirement Fund
New York State Common Retirement Fund lowered its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 2.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional... More of this article »
New York State Common Retirement Fund Has $848,000 Position in Brinker International, Inc. (NYSE:EAT)
New York State Common Retirement Fund lowered its stake in shares of Brinker International, Inc. (NYSE:EAT – Free Report) by 37.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange... More of this article »
Victory Capital Management Inc. Raises Holdings in Commvault Systems, Inc. (NASDAQ:CVLT)
Victory Capital Management Inc. grew its position in shares of Commvault Systems, Inc. (NASDAQ:CVLT – Free Report) by 1.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission... More of this article »
HC Wainwright Reiterates Buy Rating for PDS Biotechnology (NASDAQ:PDSB)
HC Wainwright reaffirmed their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $21.00 target price... More of this article »
Jefferies Financial Group Cuts Uber Technologies (NYSE:UBER) Price Target to $100.00
Uber Technologies (NYSE:UBER – Free Report) had its price target decreased by Jefferies Financial Group from $103.00 to $100.00 in a research report released on Thursday, Benzinga reports. Jefferies Financial Group currently... More of this article »
Olema Pharmaceuticals (NASDAQ:OLMA) PT Raised to $28.00 at HC Wainwright
Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) had its price target upped by HC Wainwright from $25.00 to $28.00 in a research report released on Thursday morning, Benzinga reports. HC Wainwright currently has a buy rating... More of this article »
Jefferies Financial Group Cuts KKR & Co. Inc. (NYSE:KKR) Price Target to $113.00
KKR & Co. Inc. (NYSE:KKR – Free Report) had its price objective lowered by Jefferies Financial Group from $115.00 to $113.00 in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently... More of this article »
The Carlyle Group (NASDAQ:CG) Price Target Cut to $44.00 by Analysts at Jefferies Financial Group
The Carlyle Group (NASDAQ:CG – Free Report) had its target price decreased by Jefferies Financial Group from $49.00 to $44.00 in a report released on Thursday morning, Benzinga reports. Jefferies Financial Group currently has... More of this article »
Context Therapeutics (NASDAQ:CNTX) PT Raised to $5.00
Context Therapeutics (NASDAQ:CNTX – Free Report) had its target price increased by HC Wainwright from $4.00 to $5.00 in a report published on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Separately,... More of this article »
Mizuho Increases Emerson Electric (NYSE:EMR) Price Target to $135.00
Emerson Electric (NYSE:EMR – Free Report) had its target price raised by Mizuho from $130.00 to $135.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a buy rating on the industrial... More of this article »